ALS is a progressive neurodegenerative disease that affects motor neurons and leads muscle weakness and atrophy. It is very difficult to diagnose since a number of diseases mimic the symptoms of ALS. To date, no diagnostic exists for ALS.
Through its work with the ALS Association (initialand expandedstudies), Metabolon is pursuing a number of markers to distinguish people with ALS from those with mimic symptoms. These markers are being incorporated into the ALStar™ diagnostic test.
